早产且出生时生长受限婴儿的新生儿发病率与长期神经学结局的关联:TRUFFLE 的二次分析
该研究为 TRUFFLE 随机试验的二次分析,纳入 402 例早期胎儿生长受限后的存活儿童,探讨新生儿发病率与 2 岁神经发育障碍的关联。结果显示新生儿发病率见于 104 例(26%),有神经发育障碍的 39 例中 17 例(44%)曾发生新生儿发病率,高于结局正常者的 87/363(24%),比值比 2.5(95%CI 1.3-4.8),P=0.01。作者认为除颅脑超声异常外,常用新生儿发病率是后期神经发育障碍的较差标志物,不应作为替代结局。
要点
- 新生儿发病率见于 104/402 例(26%),神经发育障碍见于 39 例。
- 有神经发育障碍的 39 例中 17 例(44%)曾发生新生儿发病率。
- 22/39 例神经发育障碍(56%)之前无新生儿发病率。
核心结论
- 除颅脑超声异常外,常用新生儿发病率是后期神经发育障碍的较差标志物,不应作为神经发育障碍的替代结局。
研究设计与样本
- 欧洲随机试验 TRUFFLE 的二次分析,研究对象为依赖静脉多普勒或胎心监护标准决定分娩的极早产胎儿。
- 共纳入 402 例早期胎儿生长受限后的存活儿童,前瞻性收集从识别胎儿生长受限至纠正年龄 2 岁的数据。
- 所有统计模型均保留试验分组。
主要发现
- 新生儿发病率见于 104 例(26%)。
- 有神经发育障碍的 39 例中 17 例(44%)曾发生新生儿发病率,高于结局正常的 363 例中 87 例(24%),比值比 2.5(95%CI 1.3-4.8),P=0.01。
- 39 例神经发育障碍中 22 例(56%)之前无新生儿发病率。
- 新生儿发病率与胎龄呈负相关,但神经发育障碍不随胎龄变化。
- 多变量分析中,颅脑超声异常与神经发育障碍的关联最强,其次为试验分组、出生体重比、婴儿性别和 Apgar 评分。
关键数值与推荐
- 新生儿发病率定义为支气管肺发育不良、脑损伤、脓毒症或坏死性小肠结肠炎中任一项。
- 神经发育障碍定义为 Bayley 认知评分<85、脑性瘫痪或严重感觉障碍的复合结局。
临床怎么用
- 作者认为除颅脑超声异常外,常用新生儿发病率不应作为神经发育障碍的替代结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the relationship between neonatal morbidity (NNM) and two-year neurodevelopmental impairment (NDI) in surviving children after early fetal growth restriction (FGR). DESIGN: Secondary analysis of a European randomised trial (TRUFFLE) of delivery for very preterm fetuses dependent on venous Doppler or cardiotocographic criteria. SETTING: Tertiary perinatal centres, participants in TRUFFLE. POPULATION: 402 surviving children after early FGR. METHODS: Prospective data were collection from the recognition of FGR until the corrected age of two years. We studied the association between NNM and NDI, retaining trial allocation in all statistical models. NNM included any of bronchopulmonary dysplasia, brain injury, sepsis or necrotising enterocolitis. NDI was a composite of Bayley cognitive score < 85, cerebral palsy or severe sensory impairment. MAIN OUTCOME MEASURE: NDI in relation to NNM. RESULTS: NNM occurred in 104 cases (26%) and was more frequent in 17 of 39 infants with NDI (44%) than in the 87 of 363 infants with normal outcome (24%) [odds ratio 2.5 (95% CI, 1.3-4.8); P = 0.01]. In 22 of 39 NDI cases (56%) there was no preceding NNM. NNM was inversely related to gestational age, but NDI did not vary by gestational age. In multivariable analyses, cerebral ultrasound abnormalities were most strongly associated with NDI, together with trial group allocation, birthweight ratio, infant sex and Apgar score. CONCLUSIONS: With the exception of cerebral ultrasound abnormalities, commonly used NNMs are poor markers of later NDI and should not be used as surrogate outcomes for NDI. TWEETABLE ABSTRACT: Neonatal morbidities cannot be used as surrogate outcomes for neurodevelopmental impairment.
引用
- Van Wassenaer-Leemhuis AG, Marlow N, Lees C, et al. The association of neonatal morbidity with long-term neurological outcome in infants who were growth restricted and preterm at birth: secondary analyses from TRUFFLE (Trial of Randomized Umbilical and Fetal Flow in Europe). BJOG. 2017. PMID: 28158932. doi:10.1111/1471-0528.14511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。